Search filters

List of works by Eudocia Q Lee

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

scientific article

A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma

scientific article

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

scientific article published on 21 February 2016

ACTR-17. EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, FINAL RESULTS OF A MULTICENTER PHASE II STUDY

ACTR-76. FINAL RESULTS FROM A PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA.

scientific article published on 6 November 2017

ACTR-93. A PHASE I STUDY OF MLN0128 (TAK-228) AND BEVACIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS INCLUDING GLIOBLASTOMA

ACTR-95. HYPOXIA ACTIVATED EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, A MULTICENTER PHASE II STUDY

AT-36PANOBINOSTAT IN COMBINATION WITH BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA AND ANAPLASTIC GLIOMA

AT-37PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA.

scientific article published in November 2014

ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA.

scientific article

ATNT-14PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA.

scientific article

ATNT-18A PHASE I STUDY OF MLN0128 AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA AND OTHER SOLID TUMORS.

scientific article

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma

scientific article

Advances in Management of Brain and Leptomeningeal Metastases

scientific article published on 06 June 2020

Assessment of Brain Tumor Response: RANO and Its Offspring

scientific article published on July 2016

Atypical and anaplastic meningiomas treated with bevacizumab.

scientific article published on 29 April 2012

Barriers to Accrual and Enrollment in Brain Tumor Trials

scientific article published on 07 June 2019

Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma ⬇️

scientific article published on May 29, 2012

Brain Metastases

scientific article published on 18 June 2018

Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.

scientific article

Brain Tumors

scientific article published on 22 January 2018

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

scientific article published on 04 February 2019

CMET-20. EVIDENCE OF CNS RESPONSE OF PEMBROLIZUMAB FOR LEPTOMENINGEAL CARCINOMATOSIS AT A SINGLE CELL RESOLUTION

CTIM-07. IDENTIFICATION OF A BASELINE BIOMARKER ASSOCIATED WITH TUMOR RESPONSES IN A PHASE I/IIa TRIAL OF A THERAPEUTIC CMV VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM)

scientific article published in November 2020

Central Nervous System Complications of Cancer Therapy ⬇️

scientific article published on April 27, 2012

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

scientific article

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

scientific article

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

scientific article published on September 2013

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma

scientific article

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

scientific article published in January 2018

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

scientific article published in January 2018

Computationally simple analysis of matched, outcome-based studies of ordinal disease states

scientific article published on 22 April 2015

Corticosteroids for peritumoral edema: time to overcome our addiction?

scientific article published on 16 August 2016

Current and future directions for Phase II trials in high-grade glioma ⬇️

scientific article published on April 1, 2013

Current clinical development of PI3K pathway inhibitors in glioblastoma ⬇️

scientific article published on May 22, 2012

Epidemiology of brain metastases

scientific article published in February 2012

Evaluation of the response assessment criteria in newly diagnosed and recurrent glioblastoma.

scientific article published in 2022

Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma

scientific article published on 08 June 2020

Extent of resection and overall survival for patients with atypical and malignant meningioma

scientific article published on 26 August 2015

First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma

scientific article published on 14 January 2020

Gender and sex disparity in cancer trials

scientific article published on 01 August 2020

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

scientific article published on 12 October 2021

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions

scientific article published on 24 April 2020

HOUT-28. OFF-LABEL USE OF PD-1 BLOCKADE WITH OR WITHOUT BEVACIZUMAB CONFERS ONLY LIMITED CLINICAL BENEFIT IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the field

scientific article published on 28 January 2020

Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients

scientific article published on April 2015

Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis

scientific article published on 26 November 2020

Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation

scientific article published on 2 February 2018

Importance of Extracranial Disease Status and Tumor Subtype for Patients Undergoing Radiosurgery for Breast Cancer Brain Metastases ⬇️

scientific article published on July 15, 2012

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study

scientific article published on 24 April 2017

Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation

scientific article

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

scientific article published on 27 March 2019

Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation

scientific article

Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis

scientific article published on 11 September 2019

Is it time to reconsider the role of irinotecan for the treatment of high-grade gliomas?

scientific article published on 01 July 2018

Letter: When Less is More: Dexamethasone Dosing for Brain Tumors

scientific article published on 01 September 2019

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

Local control after brain-directed radiation in patients with cystic versus solid brain metastases

scientific article published on 04 February 2019

Local control after fractionated stereotactic radiation therapy for brain metastases

scientific article published on 25 July 2014

MNGO-01A PROGNOSTIC CYTOGENETIC SCORING SYSTEM TO GUIDE THE ADJUVANT MANAGEMENT OF PATIENTS WITH ATYPICAL MENINGIOMA.

scientific article

Mechanisms and therapeutic implications of hypermutation in gliomas

scientific article published on 15 April 2020

Medical management of brain tumors and the sequelae of treatment

scientific article

NI-36VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB.

scientific article published in November 2014

NIMG-63. ADVANCED IMAGING FOR ASSESSING VOLUMETRIC RESPONSES IN BRAIN METASTASES TREATED WITH CHECKPOINT BLOCKADE

scientific article published on 5 November 2018

NIMG-68. MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE

NIMG-98. ASSESSMENT OF TUMOR HYPOXIA AND PERFUSION IN GBM FOLLOWING BEV FAILURE USING FMISO 18F-PET AND MRI.

scientific article published on 6 November 2017

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

scientific article published on 10 March 2020

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

article

Nervous system metastases from systemic cancer

scientific article published on April 2015

Neurologic Complications in Patients With Cancer

scientific article published on 01 December 2020

Neurologic complications of cancer drug therapies

scientific article published on April 2012

O7.01RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR BRAIN METASTASES.

scientific article published in September 2014

ONGOING CLINICAL TRIALS

article

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

scientific article published on 24 January 2020

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion

scientific article

PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma

scientific article published on 31 August 2018

PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM.

scientific article published in July 2014

Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.

scientific article published on 19 December 2017

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma

scientific article

Phase I and biomarker study of plerixafor and bevacizumab in recurrent high-grade glioma.

scientific article

Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma ⬇️

scientific article published on October 8, 2011

Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

scientific article

Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Final Results of Alliance N0874/ABTC 02.

scientific article published on 22 August 2017

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

scientific article

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

scientific article

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

scientific article

Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma

scientific article published on 24 August 2019

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

scientific article

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas

scientific article published on 22 October 2014

Prospective Study of Inflammatory Biomarkers and Risk of Diabetic Retinopathy in the Diabetes Control and Complications Trial ⬇️

scientific article published on April 1, 2013

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 18 June 2020

Reply to B. Freidlin et al ⬇️

scientific article published on March 1, 2013

Response Assessment in Neuro-Oncology Clinical Trials.

scientific article published on 22 June 2017

Response assessment criteria for brain metastases: proposal from the RANO group.

scientific article

Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab

scientific article

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma ⬇️

scientific article published on 05 July 2013

SM-03A RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL OF ARMODAFINIL FOR FATIGUE IN PATIENTS WITH GLIOMAS UNDERGOING RADIOTHERAPY.

scientific article published in November 2014

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone

scientific article published on 3 October 2017

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 01 June 2020

Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy

scientific article published on 4 August 2014

The Evolving Landscape of Brain Metastasis.

scientific article published on 21 February 2018

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

scientific article published on 21 October 2015

The Interface Between Neurology and Oncology

scientific article published on 13 June 2018

The role of MGMT testing in clinical practice: a report of the association for molecular pathology

scientific article

The role of whole brain radiation therapy in the management of melanoma brain metastases

scientific article

To add IT chemotherapy, or not to add, that is the question

scientific article published on 13 February 2020

Treatment Options in Newly Diagnosed Glioblastoma ⬇️

scientific article published on June 1, 2013

Update on bevacizumab and other angiogenesis inhibitors for brain cancer ⬇️

scientific article published on May 14, 2013

Updates in the management of brain metastases.

scientific article

WNT-Activated Medulloblastomas With Hybrid Molecular Subtypes

scientific article published on 14 April 2020

Paulina is supported by:

About Paulina

Help